Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDER'S EQUITY

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDER'S EQUITY - USD ($)
$ in Thousands
Total
At The Market
Common Stock
Common Stock
At The Market
Additional Paid-In Capital
Additional Paid-In Capital
At The Market
Accumulated Other Comprehensive (Loss) Gain
Accumulated Deficit
Balance at Dec. 31, 2018 $ 78,586   $ 34   $ 296,100   $ (3) $ (217,545)
Balance (in shares) at Dec. 31, 2018     33,765,864          
Exercise of stock options 3       3      
Exercise of stock options, Shares     1,077          
Stock-based compensation expense 1,879       1,879      
Other comprehensive gain (loss) 11           11  
Net loss (16,461)             (16,461)
Balance at Mar. 31, 2019 64,018   $ 34   297,982   8 (234,006)
Balance (in shares) at Mar. 31, 2019     33,766,941          
Balance at Dec. 31, 2018 78,586   $ 34   296,100   (3) (217,545)
Balance (in shares) at Dec. 31, 2018     33,765,864          
Net loss (75,400)              
Balance at Dec. 31, 2019 $ 79,184   $ 43   372,100   24 (292,983)
Balance (in shares) at Dec. 31, 2019 43,367,801   43,367,801          
Exercise of stock options $ 100       100      
Exercise of stock options, Shares 30,595   30,595          
Vesting of restricted stock units, Shares     90,512          
Issuance of common stock, net of issuance costs   $ 11,919   $ 2   $ 11,917    
Issuance of common stock, net of issuance costs (in shares)       2,201,810        
Issuance of warrants $ 128       128      
Stock-based compensation expense 2,459       2,459      
Other comprehensive gain (loss) (21)           (21)  
Net loss (17,226)             (17,226)
Balance at Mar. 31, 2020 $ 76,543   $ 45   $ 386,704   $ 3 $ (310,209)
Balance (in shares) at Mar. 31, 2020 45,690,718   45,690,718